These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 28343354)

  • 41. Real-Time PCR Assay for Detection and Differentiation of Shiga Toxin-Producing Escherichia coli from Clinical Samples.
    Qin X; Klein EJ; Galanakis E; Thomas AA; Stapp JR; Rich S; Buccat AM; Tarr PI
    J Clin Microbiol; 2015 Jul; 53(7):2148-53. PubMed ID: 25926491
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hemolytic uremic syndrome caused by Shiga toxin-producing Escherichia coli in children: incidence, risk factors, and clinical outcome.
    Ylinen E; Salmenlinna S; Halkilahti J; Jahnukainen T; Korhonen L; Virkkala T; Rimhanen-Finne R; Nuutinen M; Kataja J; Arikoski P; Linkosalo L; Bai X; Matussek A; Jalanko H; Saxén H
    Pediatr Nephrol; 2020 Sep; 35(9):1749-1759. PubMed ID: 32323005
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fecal diagnostics in combination with serology: best test to establish STEC-HUS.
    Wijnsma KL; van Bommel SA; van der Velden T; Volokhina E; Schreuder MF; van den Heuvel LP; van de Kar NC
    Pediatr Nephrol; 2016 Nov; 31(11):2163-70. PubMed ID: 27240858
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Eculizumab in Shiga toxin-producing Escherichia coli hemolytic uremic syndrome: a systematic review.
    de Zwart PL; Mueller TF; Spartà G; Luyckx VA
    Pediatr Nephrol; 2024 May; 39(5):1369-1385. PubMed ID: 38057431
    [TBL] [Abstract][Full Text] [Related]  

  • 45. O80:H2-Associated Hemolytic Uremic Syndrome without Hemorrhagic Colitis: A Case Report.
    Yoshida S; Tanaka E; Kiuchi Z; Nunokawa S; Kawahara A; Iyoda S; Narita M
    Case Rep Nephrol Dial; 2024; 14(1):97-103. PubMed ID: 39015121
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Shiga toxin-producing Escherichia coli O171:H25 strain isolated from a patient with haemolytic uraemic syndrome.
    Lepšanović Z; Opačić D; Lazić S; Herpay M; Tóth S; Kostić M; Kucsera I
    Acta Microbiol Immunol Hung; 2012 Jun; 59(2):215-24. PubMed ID: 22750781
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Soluble plasma VE-cadherin concentrations are elevated in patients with STEC infection and haemolytic uraemic syndrome: a case-control study.
    Doulgere J; Otto B; Nassour M; Wolters-Eisfeld G; Rohde H; Magnus T; Wagener C; Streichert T
    BMJ Open; 2015 Mar; 5(3):e005659. PubMed ID: 25757942
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ockham's razor defeated: about two atypical cases of hemolytic uremic syndrome.
    Schwarz C; Brehon A; Mousseaux C; Luque Y; Senet P; Mariani P; Mohamadou I; Zafrani L; Frémeaux-Bacchi V; Rondeau E; Buob D; Rafat C
    BMC Nephrol; 2020 Jul; 21(1):269. PubMed ID: 32652955
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Outbreak of hemolytic uremic syndrome with unusually severe clinical presentation caused by Shiga toxin-producing Escherichia coli O26:H11 in France.
    Minary K; Tanne C; Kwon T; Faudeux C; Clave S; Langevin L; Pietrement C; Enoch C; Parmentier C; Mariani-Kurkdjian P; Weill FX; Jones G; Djouadi N; Morin D; Fila M
    Arch Pediatr; 2022 Aug; 29(6):448-452. PubMed ID: 35662540
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of Shiga toxin production by hemolytic-uremic syndrome-associated and bovine-associated Shiga toxin-producing Escherichia coli isolates.
    Ritchie JM; Wagner PL; Acheson DW; Waldor MK
    Appl Environ Microbiol; 2003 Feb; 69(2):1059-66. PubMed ID: 12571029
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Shiga toxin-induced haemolytic uraemic syndrome and the role of antibiotics: a global overview.
    Kakoullis L; Papachristodoulou E; Chra P; Panos G
    J Infect; 2019 Aug; 79(2):75-94. PubMed ID: 31150744
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hemolytic uremic syndrome in children.
    Talarico V; Aloe M; Monzani A; Miniero R; Bona G
    Minerva Pediatr; 2016 Dec; 68(6):441-455. PubMed ID: 27768015
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Strong association between shiga toxin-producing Escherichia coli O157 and virulence genes stx2 and eae as possible explanation for predominance of serogroup O157 in patients with haemolytic uraemic syndrome.
    Werber D; Fruth A; Buchholz U; Prager R; Kramer MH; Ammon A; Tschäpe H
    Eur J Clin Microbiol Infect Dis; 2003 Dec; 22(12):726-30. PubMed ID: 14614596
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ongoing haemolytic uraemic syndrome (HUS) outbreak caused by sorbitol-fermenting (SF) Shiga toxin-producing Escherichia coli (STEC) O157, Germany, December 2016 to May 2017.
    Vygen-Bonnet S; Rosner B; Wilking H; Fruth A; Prager R; Kossow A; Lang C; Simon S; Seidel J; Faber M; Schielke A; Michaelis K; Holzer A; Kamphausen R; Kalhöfer D; Thole S; Mellmann A; Flieger A; Stark K
    Euro Surveill; 2017 May; 22(21):. PubMed ID: 28597831
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Combined usage of serodiagnosis and O antigen typing to isolate Shiga toxin-producing
    Lee K; Iguchi A; Terano C; Hataya H; Isobe J; Seto K; Ishijima N; Akeda Y; Ohnishi M; Iyoda S;
    Microbiol Spectr; 2024 Jan; 12(1):e0235523. PubMed ID: 38092668
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Characterization and epidemiologic subtyping of Shiga toxin-producing Escherichia coli strains isolated from hemolytic uremic syndrome and diarrhea cases in Argentina.
    Rivas M; Miliwebsky E; Chinen I; Roldán CD; Balbi L; García B; Fiorilli G; Sosa-Estani S; Kincaid J; Rangel J; Griffin PM;
    Foodborne Pathog Dis; 2006; 3(1):88-96. PubMed ID: 16602984
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Shiga toxin-producing Escherichia coli in household members of children with hemolytic uremic syndrome.
    Alconcher LF; Rivas M; Lucarelli LI; Galavotti J; Rizzo M
    Eur J Clin Microbiol Infect Dis; 2020 Mar; 39(3):427-432. PubMed ID: 31782026
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A case of hemolytic uremic syndrome caused by Shiga toxin-producing Escherichia coli after pericardiectomy.
    Tome J; Maselli DB; Im R; Amdahl MB; Pfeifle D; Hagen C; Halland M
    Clin J Gastroenterol; 2022 Feb; 15(1):123-127. PubMed ID: 34677733
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bacterial genetic determinants of non-O157 STEC outbreaks and hemolytic-uremic syndrome after infection.
    Wickham ME; Lupp C; Mascarenhas M; Vazquez A; Coombes BK; Brown NF; Coburn BA; Deng W; Puente JL; Karmali MA; Finlay BB
    J Infect Dis; 2006 Sep; 194(6):819-27. PubMed ID: 16941350
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genomic surveillance of STEC/EHEC infections in Germany 2020 to 2022 permits insight into virulence gene profiles and novel O-antigen gene clusters.
    Fruth A; Lang C; Größl T; Garn T; Flieger A
    Int J Med Microbiol; 2024 Mar; 314():151610. PubMed ID: 38310676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.